Cargando…

Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcγRIIB

Rheumatoid arthritis (RA) is a complex autoimmune disease with a poorly understood pathogenesis. The disease is associated with polyclonal B cell activation and the production of autoantibodies (autoAbs), but there is a longstanding controversy as to whether such Abs contribute to, or are secondary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petkova, Stefka B., Konstantinov, Konstantin N., Sproule, Thomas J., Lyons, Bonnie L., Awwami, Moheeb Al, Roopenian, Derry C.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Brief Definitive Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118221/ https://www.ncbi.nlm.nih.gov/pubmed/16476768 http://dx.doi.org/10.1084/jem.20051951

Ejemplares similares

Negative Signaling Pathways of the Killer Cell Inhibitory Receptor and FcγRIIb1 Require Distinct Phosphatases
por: Gupta, Neetu, et al.
Publicado: (1997)

FcγRIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis
por: Clatworthy, Menna R., et al.
Publicado: (2004)

Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells
por: Burton, Oliver T., et al.
Publicado: (2018)

Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018)

Role of lipid nanodomains for inhibitory FcγRIIb function
por: Spiegel, Franziska, et al.
Publicado: (2023)

High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis
por: Magnusson, Sofia E, et al.
Publicado: (2007)

IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells
por: Gast, Mathias, et al.
Publicado: (2018)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)

The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019)

Distinct cell-specific control of autoimmunity and infection by FcγRIIb
por: Brownlie, Rebecca J., et al.
Publicado: (2008)

FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021)

Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway
por: Ye, Lilin, et al.
Publicado: (2011)

Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB(−/−) Mice
por: Bolland, Silvia, et al.
Publicado: (2002)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
por: Dhodapkar, Kavita M., et al.
Publicado: (2007)

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
por: Dhodapkar, Kavita M., et al.
Publicado: (2007)

The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan
por: Chaudhury, Chaity, et al.
Publicado: (2003)

Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
por: Crowley, Andrew R., et al.
Publicado: (2023)

Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
por: Karimifar, Mansoor, et al.
Publicado: (2021)

Downmodulation of Vaccine-Induced Immunity and Protection against the Intracellular Bacterium Francisella tularensis by the Inhibitory Receptor FcγRIIB
por: Franz, Brian J., et al.
Publicado: (2015)

Testing the role of the FcγRIIB immunoreceptor tyrosine-based inhibitory motif in regulation of the B cell immune response
por: Vuyyuru, Raja, et al.
Publicado: (2015)

Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function
por: Zhu, Tianyi, et al.
Publicado: (2016)

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
por: Teige, Ingrid, et al.
Publicado: (2019)

Identification of candidate regulators of mandibular bone loss in FcγRIIB(-/-) Mice
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
por: Shibata-Koyama, Mami, et al.
Publicado: (2009)

Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131)
por: Mimoto, F., et al.
Publicado: (2013)

Correction to: Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
por: Karimifar, Mansoor, et al.
Publicado: (2022)

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
por: Georgescu, Maria T., et al.
Publicado: (2020)

B Lymphocyte Memory: Role of Stromal Cell Complement and FcγRIIB Receptors
por: Barrington, Robert A., et al.
Publicado: (2002)

Dexamethasone Induces FcγRIIb Expression in RBL-2H3 Cells
por: Silwal, Prashanta, et al.
Publicado: (2012)

FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
por: Hu, Wei, et al.
Publicado: (2019)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signalling
por: Patin, Emmanuel C., et al.
Publicado: (2017)

Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
por: Victor, Jefferson R, et al.
Publicado: (2010)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

FcγRIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma
por: Dharajiya, Nilesh, et al.
Publicado: (2010)

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
por: Li, Fubin, et al.
Publicado: (2012)

FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape
por: Wu, Lei, et al.
Publicado: (2022)

FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation
por: Barlev, Ashley N., et al.
Publicado: (2022)

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking
por: Liu, Luyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pcug1bl4q2pj14t45l5799vb36